| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash | 31,855 | 18,571 | 32,565 | 27,013 |
| Prepaid expenses and other current assets | 6,696 | 5,769 | 5,074 | 5,870 |
| Total current assets | 38,551 | 24,340 | 37,639 | 32,883 |
| Property and equipment, net | 13,830 | 14,392 | 14,946 | 15,445 |
| Restricted cash | 318 | 316 | 314 | 312 |
| Other assets | 4,206 | 4,468 | 4,697 | 4,954 |
| Total assets | 56,905 | 43,516 | 57,596 | 53,594 |
| Accounts payable | 3,241 | 6,202 | 4,574 | 4,237 |
| Accrued expenses and other current liabilities | 11,612 | 14,733 | 14,932 | 12,899 |
| Operating lease obligations | 850 | 858 | 855 | 853 |
| Current portion of long-term debt | 5,005 | 1,250 | 0 | 0 |
| Total current liabilities | 20,708 | 23,043 | 20,361 | 17,989 |
| Operating lease obligations, less current portion | 3,252 | 3,494 | 3,709 | 3,945 |
| Long term debt, net | 24,189 | 27,542 | 28,400 | 28,025 |
| Other non-current liabilities | 2,951 | 1,603 | 1,593 | 583 |
| Total non-current liabilities | 30,392 | 32,639 | 33,702 | 32,553 |
| Total liabilities | 51,100 | 55,682 | 54,063 | 50,542 |
| Series b convertible preferred stock zero shares issued and outstanding at december31, 2025 and 2024 | NaN | 0 | NaN | NaN |
| Common stock 0.01 par value 390,000,000 shares authorized, 338,440,399 and 312,501,472 shares issued, and 338,318,899 and 312,379,972 shares outstanding at march31, 2026 and december31, 2025, respectively | 3,384 | 3,125 | 3,125 | 2,924 |
| Treasury stock, at cost, 121,500 shares at march31, 2026 and december31, 2025 | 48 | 48 | 48 | 48 |
| Additional paid-in capital | 429,549 | 392,763 | 390,759 | 370,474 |
| Accumulated other comprehensive income | 164 | 61 | 58 | 12 |
| Accumulated deficit | -427,244 | -408,067 | -390,361 | -370,310 |
| Total stockholders' equity | 5,805 | -12,166 | 3,533 | 3,052 |
| Total liabilities and stockholders' equity | 56,905 | 43,516 | 57,596 | 53,594 |
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)